Understanding how proteins communicate in the CRISPR-Cas9 system
Studies of Allostery between Multi-domain Proteins and Nucleic Acid Complexes
This study is exploring how the CRISPR-Cas9 gene-editing tool works at a molecular level, which could help make treatments for diseases more precise and effective for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10740890 on NIH RePORTER |
What this research studies
This research investigates how the CRISPR-Cas9 system, which is used for genome editing, communicates through allosteric pathways involving proteins and nucleic acids. By using advanced techniques like solution NMR and molecular dynamics, the researchers aim to uncover the mechanisms that enhance the precision and effectiveness of CRISPR-Cas9. This understanding could lead to improved applications in bioengineering and precision medicine, ultimately benefiting patients through more targeted therapies. The study combines experimental and computational methods to analyze the flexibility and functionality of these complex biological systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders that could potentially be treated using CRISPR-Cas9 technology.
Not a fit: Patients with conditions that are not amenable to genome editing or those who do not have genetic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective genome editing therapies for various genetic conditions.
How similar studies have performed: Previous research has shown promising results in understanding allosteric mechanisms in protein systems, indicating that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Batista, Victor S — Yale University
- Study coordinator: Batista, Victor S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.